New CAR-T cells offer on-demand control for cancer treatment
Ludwig Cancer Research scientists have devised new types of chimeric antigen-receptor (CAR) T cells—a type of cancer ...
中华网21 小时
制药巨头双抗业务版图：罗氏领跑，强生三面进击，阿斯利康 ...
这其中也不乏制药巨头的重量级押注。8月，默沙东以7亿美元的首付款将同润生物一款处于I期阶段的CD3/CD19双抗CN201收入囊中。7月，诺华与Dren Bio就髓系细胞募集双抗的开发达成合作，交易总额达30亿美元。
marketindex16 天
CD Private Equity Fund Iii (CD3)
Data supplied by Morningstar and accurate on Apr 30, 2024. It's not possible to publish a real-time Top 20 Shareholder list. Companies are not obliged to report this data (with the exception of ...
Cancer Research19 天
CD28 Costimulation Augments CAR Signaling in NK Cells via the LCK/CD3ζ/ZAP70 Signaling Axis
Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas. *Corresponding Author: Katayoun Rezvani, Department of Stem Cell ...
The New England Journal of Medicine21 天
Aggressive Lymphoma after CD19 CAR T-Cell Therapy
Panel D shows multiparametric flow cytometry analysis indicating that 89% of the CD3+ cells from a bone marrow aspiration on day 52 showed the expression of the anti-CD19 CAR. Side scatter values ...